Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs

被引:19
|
作者
Jin, Haolun [1 ]
Wright, Matthew [1 ]
Pastor, Richard [1 ]
Mish, Michael [1 ]
Metobo, Sammy [1 ]
Jabri, Salman [1 ]
Lansdown, Rachael [1 ]
Cai, Ruby [1 ]
Pyun, Peter [1 ]
Tsiang, Manuel [1 ]
Chen, Xiaowu [1 ]
Kim, Choung U. [1 ]
机构
[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA
关键词
D O I
10.1016/j.bmcl.2008.01.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of C5-aza tricyclic HIV integrase inhibitors was prepared. A highly potent and orally bioavailable compound ( compound 9) was identified and selected for development. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1388 / 1391
页数:4
相关论文
共 50 条
  • [41] Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
    Prime, Michael E.
    Courtney, Stephen M.
    Brookfield, Frederick A.
    Marston, Richard W.
    Walker, Victoria
    Warne, Justin
    Boyd, Andrew E.
    Kairies, Norman A.
    von der Saal, Wolfgang
    Limberg, Anja
    Georges, Guy
    Engh, Richard A.
    Goller, Bernhard
    Rueger, Petra
    Rueth, Matthias
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 312 - 319
  • [42] Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors
    Thomson, Joanne L.
    Blackaby, Wesley P.
    Jennings, Andrew S. R.
    Goodacre, Simon C.
    Pike, Andrew
    Thomas, Steve
    Brown, Terry A.
    Smith, Alison
    Pillai, Gopalan
    Street, Leslie J.
    Lewis, Richard T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2235 - 2239
  • [43] Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin K
    Tavares, FX
    Boncek, V
    Deaton, DN
    Hassell, AM
    Long, ST
    Miller, AB
    Payne, AA
    Miller, LR
    Shewchuk, LM
    Wells-Knecht, K
    Willard, DH
    Wright, LL
    Zhou, HQ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 588 - 599
  • [44] Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors
    Harada, Koichiro
    Kubo, Hideki
    Abe, Jun
    Haneta, Mari
    Conception, Arnel
    Inoue, Shinichi
    Okada, Satoshi
    Nishioka, Kazuhiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (10) : 3242 - 3254
  • [45] Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors
    Duan, James J. -W.
    Chen, Lihua
    Lu, Zhonghui
    Xue, Chu-Biao
    Liu, Rui-Qin
    Covington, Maryanne B.
    Qian, Mingxin
    Wasserman, Zelda R.
    Vaddi, Krishna
    Christ, David D.
    Trzaskos, James M.
    Newton, Robert C.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 241 - 246
  • [46] Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors
    Sperandio, David
    Tai, Vincent W. -F.
    Lohman, Julia
    Hirschbein, Bernie
    Mendonca, Rohan
    Lee, Chang-Sun
    Spencer, Jeffrey R.
    Janc, James
    Nguyen, Margaret
    Beltman, Jerlyn
    Sprengeler, Paul
    Scheerens, Heleen
    Lin, Tong
    Liu, Liang
    Gadre, Ashwini
    Kellogg, Alisha
    Green, Michael J.
    McGrath, Mary E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4085 - 4089
  • [47] Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors
    Hua, Zihao
    Bregman, Howard
    Buchanan, John L.
    Chakka, Nagasree
    Guzman-Perez, Angel
    Gunaydin, Hakan
    Huang, Xin
    Gu, Yan
    Berry, Virginia
    Liu, Jingzhou
    Teffera, Yohannes
    Huang, Liyue
    Egge, Bryan
    Emkey, Renee
    Mullady, Erin L.
    Schneider, Steve
    Andrews, Paul S.
    Acquaviva, Lisa
    Dovey, Jennifer
    Mishra, Ankita
    Newcomb, John
    Saffran, Douglas
    Serafino, Randy
    Strathdee, Craig A.
    Turci, Susan M.
    Stanton, Mary
    Wilson, Cindy
    DiMauro, Erin F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 10003 - 10015
  • [48] Discovery and optimization of potent, selective, and orally bioavailable Jak1 inhibitors
    Zak, Mark
    Johnson, Adam
    Van Abbema, Anne
    Waszkowycz, Bohdan
    Eigenbrot, Charles
    Chang, Christine
    Hurley, Christopher
    Hanan, Emily
    Kenny, Jane
    Kulagowski, Janusz
    DeVoss, Jason
    Murray, Jeremy
    Balazs, Mercedesz
    Steffek, Micah
    Koehler, Michael
    Ghilardi, Nico
    Chakravarty, Paroma
    Lupardus, Patrick
    Gibbons, Paul
    Dragovich, Peter
    Bergeron, Philippe
    Pulk, Rebecca
    Mendonca, Rohan
    Savage, Scott
    Labadie, Sharada
    Gradl, Stefan
    Ward, Stuart
    Blair, Wade
    Jia, Wei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [49] Structure-guided design of potent, selective, and orally bioavailable Tankyrase inhibitors
    Bregman, Howard
    DiMauro, Erin
    Chakka, Nagasree
    Guzman-Perez, Angel
    Hua, Zihao
    Huang, Hongbing
    Martin, Matthew
    Buchanan, John
    Gunaydin, Hakan
    Huang, Xin
    Huang, Liyue
    Wilson, Cindy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [50] Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
    Cheng, Dai
    Liu, Jun
    Han, Dong
    Zhang, Guobao
    Gao, Wenqi
    Hsieh, Mindy H.
    Ng, Nicholas
    Kasibhatla, Shailaja
    Tompkins, Celin
    Li, Jie
    Steffy, Auzon
    Sun, Fangxian
    Li, Chun
    Seidel, H. Martin
    Harris, Jennifer L.
    Pan, Shifeng
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07): : 676 - 680